abbvie (NYSE: ABBV)
AbbVie Inc.
Industry: Biopharmaceutical
Abbott (NYSE: ABT)
ABBOTT LABORATORIES
Industry: Health care, Medical devices, Pharmaceutical
Period | Opening price | Closing price | Growth rate | Report date |
---|---|---|---|---|
2023Q3 | 95.450 | 114.000 | 19.43% | 2023-10-18 |
AMGEN (NASDAQ: AMGN)
Amgen Inc. (formerly Applied Molecular Genetics Inc.)
AMGEN INC
Industry: Biotechnology
AstraZeneca (NASDAQ: AZN)
AstraZeneca PLC (AZ)
ASTRAZENECA PLC
United Kingdom
Industry: Pharmaceutical, Biotechnology
Period | Opening price | Closing price | Growth rate | Report date |
---|---|---|---|---|
2024Q3 | 2024-11-12 | |||
2024Q2 | 76.140 | 64.790 | -14.91% | 2024-07-25 |
2024Q1 | 74.990 | 79.710 | 6.29% | 2024-04-25 |
2023Q4 | 61.035 | 71.200 | 16.65% | 2024-02-08 |
Bristol Myers Squibb (NYSE: BMY)
BRISTOL-MYERS SQUIBB COMPANY, doing business as Bristol Myers Squibb (BMS)
BRISTOL MYERS SQUIBB CO
Industry: Pharmaceuticals
GILEAD (NASDAQ: GILD)
GILEAD SCIENCES, INC.
Industry: Pharmaceutics, Biotechnology
Some rounding errors in the BS, IS, SOCF have been corrected.
Period | Opening price | Closing price | Growth rate | Report date |
---|---|---|---|---|
2023Q3 | 80.320 | 76.710 | -4.49% | 2023-11-07 |
Johnson&Johnson (NYSE: JNJ)
Johnson & Johnson (J&J)
JOHNSON & JOHNSON
Industry: Pharmaceutical, Medical Technology
Fiscal year end: December 31
Lilly (NYSE: LLY)
ELI LILLY AND COMPANY
ELI LILLY & Co
Industry: Pharmaceutical
Period | Opening price | Closing price | Growth rate | Report date |
---|---|---|---|---|
2024Q2 | 873.700 | 903.580 | 3.42% | 2024-08-08 |
2023Q3 | 575.900 | 704.900 | 22.40% | 2023-11-02 |
2023Q2 | 504.870 | 554.460 | 9.82% | 2023-08-08 |
MERCK (NYSE: MRK)
Merck & Co., Inc.
Industry: Pharmaceutical
Period | Opening price | Closing price | Growth rate | Report date |
---|---|---|---|---|
2023Q3 | 102.330 | 120.780 | 18.03% | 2023-10-26 |
novo nordisk (NYSE: NVO)
NOVO NORDISK A/S
NOVO NORDISK A S
Denmark
Industry: Pharmaceuticals, Health care
Financial data: DKK
Market cap: USD
Period | Opening price | Closing price | Growth rate | Report date |
---|---|---|---|---|
2024Q3 | 2024-11-06 | |||
2023Q3 | 101.280 | 109.020 | 7.64 | 2023-11-02 |
2023Q1 | 161.540 | 187.590 | 16.13% | 2023-05-04 |
NOVARTIS (NYSE: NVS)
Novartis AG
NOVARTIS AG
Switzerland
Industry: Pharmaceuticals
Pfizer (NYSE: PFE)
PFIZER INC.
PFIZER INC
Industry: Pharmaceutical, Biotechnology
Some rounding errors in the BS, IS, SOCF have been corrected.
REGENERON (NASDAQ: REGN)
REGENERON PHARMACEUTICALS, INC.
Industry: Pharmaceuticals, Biotech
Period | Opening price | Closing price | Growth rate | Report date |
---|---|---|---|---|
2023Q4 | 970.230 | 903.480 | -6.88% | 2024-02-02 |
VERTEX (NASDAQ: VRTX)
Vertex Pharmaceuticals Incorporated
VERTEX PHARMACEUTICALS INC / MA
Industry: Pharmaceuticals, Biotherapeutics
Period | Opening price | Closing price | Growth rate | Report date |
---|---|---|---|---|
2024Q3 | 2024-11-05 |
(NYSE: JNJ) Quarterly report 2024Q3
ReplyDelete(NYSE: NVS) (Quarterly) Report of foreign issuer 2024Q3
ReplyDelete(NASDAQ: REGN) Quarterly report 2024Q3
ReplyDelete(NYSE: ABT) Quarterly report 2024Q3
ReplyDelete(NYSE: LLY) Quarterly report 2024Q3
ReplyDelete(NYSE: BMY) Quarterly report 2024Q3
ReplyDelete(NYSE: PFE) Quarterly report 2024Q3
ReplyDelete(NYSE: ABBV) Quarterly report 2024Q3
ReplyDelete(NASDAQ: VRTX) Quarterly report 2024Q3
ReplyDelete(NYSE: NVO) (Quarterly) Report of foreign issuer 2024Q3
ReplyDelete(NYSE: MRK) Quarterly report 2024Q3
ReplyDelete(NASDAQ: AZN, LSE: AZN) (Quarterly) Report of foreign issuer 2024Q3
ReplyDelete(NASDAQ: GILD) Quarterly report 2024Q3
ReplyDelete(NASDAQ: AMGN) Quarterly report 2024Q3
ReplyDeleteBig Pharma Revenue Quarterly Statements 2024Q3
ReplyDeletePost a Comment